Trial Profile
Phase II Study of Testosterone Replacement in Women Experiencing Aromatase Inhibitor Side-Effects in Adjuvant Therapy for Breast Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ART2
- Sponsors HAVAH Therapeutics
- 04 Aug 2017 New trial record